It is a pharma public limited company based in Ernakulam, Kerala, India, established in 2020.
2020 | Ernakulam, Kerala, India | ActiveKainopharm Limited, a active public limited company, was established on 19 August 2020 in Ernakulam, Kerala, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33100KL2020PLC063719. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.93 Cr.
Its leadership includes Attupuram Sreekumar (Director), Mohanakurup Anjiliparambil Narayanapillai (Director), Valiyakath Anwar (Director). Past directors included Attupuram Sreekumar, Mohanakurup Anjiliparambil Narayanapillai, Valiyakath Anwar. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at #229/A- Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, 682308.
U33100KL2020PLC063719
063719
19 August 2020
₹5.00 Cr
₹3.93 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Kainopharm Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Attupuram Sreekumar | Director | 24 Aug 2020 | Current |
| Mohanakurup Anjiliparambil Narayanapillai | Director | 19 Aug 2020 | Current |
| Valiyakath Anwar | Director | 15 Nov 2020 | Current |
| Ravi Sankunny Menon | Director | 19 Aug 2020 | Current |
| Telny Thomas Chungath | Director | 24 Aug 2020 | Current |
| Anitha | Director | 15 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Nov 2021 | Past |
| Pramod Abcsdd | Managing Director | 30 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kainopharm Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Kainopharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Kainopharm has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kainopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kainopharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kainopharm Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Kainopharm Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on Valiyakath Anwar was appointed as a Director was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 15 days . was documented.
Anitha was appointed as a Director was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 15 days . was recorded as a recent event.
Kuzhalmannam Lakshminarayanan Sreeram was appointed as a Director was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 15 days . was recorded as a recent event.
Suresh Krishna Warrier was appointed as a Director was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 15 days . was recorded as a recent event.
The CIN of Kainopharm Limited is U33100KL2020PLC063719.
Kainopharm Limited is headquartered at #229/A- Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, 682308.
Kainopharm Limited was incorporated on 19 August 2020.
The current directors of Kainopharm Limited are
The primary industry of Kainopharm Limited is Pharma.
Kainopharm Limited is unlisted.
The authorized capital of Kainopharm Limited is ₹5.00 Cr, and the paid-up capital is ₹3.93 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX